DE BRAUD, FILIPPO GUGLIELMO MARIA

DE BRAUD, FILIPPO GUGLIELMO MARIA  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 576 (tempo di esecuzione: 0.004 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research 2024 Provenzano, LeonardoMazzeo, LauraSpagnoletti, AndreaGiani, ClaudiaPizzutilo, Elio GregoryLorenzini, DanieleManglaviti, SaraBeninato, TeresaLeporati, RitaAmbrosini, PaoloSerino, RobertaSilvestri, Ceciliade Braud, FilippoPruneri, GiancarloVingiani, Andrea + Article (author) -
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors 2023 Sposetti C.Leporati R.Corti C.Ligorio F.Provenzano L.Vingiani A.Sirico M.Zagami P.Boldrini L.Losurdo A.Criscitiello C.Curigliano G.Pruneri G.de Braud F. + Article (author) -
Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison 2023 Ligorio F.Rametta A.Leporati R.Depretto C.Vingiani A.Pruneri G.de Braud F. + Article (author) -
Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer 2022 Silvestri M.Dugo M.Lanzoni D.Vingiani A.de Braud F.Pruneri G. + Article (author) -
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy 2022 Boeri M.Lo Russo G.Manglaviti S.Beninato T.Bottiglieri A.Zattarin E.Galli E. G.de Braud F. G. M. + Article (author) -
Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world 2022 Bini M.de Braud F. G.Vingiani A.Pruneri G. + Article (author) -
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology 2022 Manglaviti S.Beninato T.Zattarin E.Lobefaro R.Bottiglieri A.Apollonio G.de Braud F. G. M. + Article (author) -
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with NTRK Fusion-Positive Solid Tumors 2022 De Braud, FilippoSiena, SalvatoreRolfo, Christian + Article (author) -
Impact of diabetes and metformin use on enteropancreatic neuroendocrine tumors : Post hoc analysis of the CLARINET study 2022 Mazzaferro V.de Braud F. + Article (author) -
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer 2022 Vingiani A.Corsetto P. A.Rizzo A. M.Minucci S.Foiani M.Pruneri G.de Braud F. + Article (author) -
Acquired Resistance Mechanisms to PD-L1 Blockade in a Patient With Microsatellite Instability-High Extrahepatic Cholangiocarcinoma 2022 Andrea VingianiFilippo PietrantonioFilippo de BraudGiancarlo PruneriVincenzo Mazzaferro + Article (author) -
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study 2022 Nichetti, FedericoPircher, ChiaraBini, MartaFranza, AndreaSposetti, CaterinaPruneri, GiancarloMazzaferro, VincenzoPietrantonio, Filippode Braud, Filippo + Article (author) -
Biomarker-driven immunotherapy for precision medicine in prostate cancer 2022 Ottini A.Sepe P.Beninato T.Verzoni E.Giannatempo P.De Braud F.Procopio G. + Article (author) -
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 2022 Niger, MonicaNichetti, FedericoPircher, ChiaraVingiani, AndreaAgnelli, LucaPusceddu, SaraCorti, FrancescaPrisciandaro, MicheleBini, MartaPruneri, GiancarloMazzaferro, VincenzoPietrantonio, Filippode Braud, Filippo + Article (author) -
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin 2022 Zattarin, EmmaNichetti, FedericoLigorio, FrancescaMazzeo, LauraLobefaro, RiccardoFuca, GiovanniPeverelli, GiorgiaVingiani, Andreade Braud, FilippoVernieri, Claudio + Article (author) -
Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study 2022 Raimondi, AlessandraPrisciandaro, MicheleSartore-Bianchi, AndreaDi Bartolomeo, Mariade Braud, FilippoPietrantonio, Filippo + Article (author) -
Mammographic density to predict response to neoadjuvant systemic breast cancer therapy 2022 Depretto, CDe Braud, F GVingiani, APruneri, G + Article (author) -
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer 2022 Galli, GiuliaCorsetto, Paola AntoniaBrambilla, MartaOcchipinti, MarioManglaviti, SaraVingiani, AndreaRizzo, Angela Mariade Braud, Filippo + Article (author) -
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model 2022 Azzollini, JacopoVingiani, AndreaAgnelli, LucaRosina, EricaDucceschi, MonikaNiger, MonicaDamian, Silviade Braud, FilippoPruneri, Giancarlo + Article (author) -
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21) 2022 Mennitto A.Zattarin E.Di Lorenzo G.Sepe P.Ottini A.De Braud F. G.Verzoni E. + Article (author) -